Amar R Deshpande, MD

Dr Jimenez Jimenez, who joined the Division of Transplantation and Cell Therapy in 2016, leads Sylvester's Mismatched Allogeneic Transplant Program. His clinical and research work is dedicated to improving access to Hematopoietic Cell Transplantation (HCT) for ethnically diverse patients who lack suitable donors. A national leader in mismatched HCT, Dr Jimenez chairs multiple trials and played a key role in establishing Sylvester's program. He also focuses on strategies to reduce relapse risk in patients with acute leukemias and myeloid neoplasms post-transplant.